Cargando…

Potent antibody immunity to SARS‐CoV‐2 variants elicited by a third dose of inactivated vaccine

Detalles Bibliográficos
Autores principales:	Ju, Bin, Zhou, Bing, Song, Shuo, Fan, Qing, Ge, Xiangyang, Wang, Haiyan, Cheng, Lin, Guo, Huimin, Shu, Dan, Liu, Lei, Zhang, Zheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882237/ https://www.ncbi.nlm.nih.gov/pubmed/35220661 http://dx.doi.org/10.1002/ctm2.732

Ejemplares similares

Cross-neutralization of SARS-CoV-2 Kappa and Delta variants by inactivated vaccine-elicited serum and monoclonal antibodies
por: Cheng, Lin, et al.
Publicado: (2021)

Increased resistance of SARS-CoV-2 Lambda variant to antibody neutralization
por: Guo, Huimin, et al.
Publicado: (2022)

Inactivated vaccine-elicited potent antibodies can broadly neutralize SARS-CoV-2 circulating variants
por: Liu, Yubin, et al.
Publicado: (2023)

Antibody response elicited by a third boost dose of inactivated SARS-CoV-2 vaccine can neutralize SARS-CoV-2 variants of concern
por: Yue, Lei, et al.
Publicado: (2021)

Identification and application of a pair of noncompeting monoclonal antibodies broadly binding to the nucleocapsid proteins of SARS-CoV-2 variants including Omicron
por: Zhou, Bing, et al.
Publicado: (2022)

The SARS-CoV-2 inactivated vaccine enhances the broad neutralization against variants in individuals recovered from COVID-19 up to one year
por: Zhang, Zheng, et al.
Publicado: (2022)

Omicron BQ.1.1 and XBB.1 unprecedentedly escape broadly neutralizing antibodies elicited by prototype vaccination
por: Ju, Bin, et al.
Publicado: (2023)

Sequential immunization with SARS-CoV-2 RBD vaccine induces potent and broad neutralization against variants in mice
por: Song, Shuo, et al.
Publicado: (2022)

High-density microprojection array delivery to rat skin of low doses of trivalent inactivated poliovirus vaccine elicits potent neutralising antibody responses
por: Muller, David A., et al.
Publicado: (2017)

A fourth dose of Omicron RBD vaccine enhances broad neutralization against SARS‐CoV‐2 variants including BA.1 and BA.2 in vaccinated mice
por: Zhou, Bing, et al.
Publicado: (2022)

Delta (B.1.617.2) inactivated vaccine candidate elicited neutralizing antibodies to SARS-CoV-2 and circulating variants in rhesus macaques
por: Zhang, Yanjun, et al.
Publicado: (2023)

Emerging SARS-CoV-2 B.1.621/Mu variant is prominently resistant to inactivated vaccine-elicited antibodies
por: Xie, Xiaochun, et al.
Publicado: (2021)

SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies
por: Reincke, S. Momsen, et al.
Publicado: (2022)

Previous SARS‐CoV‐2 infection or a third dose of vaccine elicited cross‐variant neutralising antibodies in vaccinated solid‐organ transplant recipients
por: Chang, Chih‐Chao, et al.
Publicado: (2022)

SARS-CoV-2 vaccination elicits broad and potent antibody effector functions to variants of concern in vulnerable populations
por: Hederman, Andrew P., et al.
Publicado: (2023)

A third (booster) dose of the inactivated SARS-CoV-2 vaccine elicits immunogenicity and T follicular helper cell responses in people living with HIV
por: Lv, Zhengchao, et al.
Publicado: (2023)

Persistence of immunity and impact of third dose of inactivated COVID-19 vaccine against emerging variants
por: Vadrevu, Krishna Mohan, et al.
Publicado: (2022)

An omicron-based vaccine booster elicits potent neutralizing antibodies against emerging SARS-CoV-2 variants in adults
por: Li, Tao, et al.
Publicado: (2023)

Viral keratitis after the second and third doses of inactivated COVID-19 vaccination: A case report
por: Shan, Huimin, et al.
Publicado: (2022)

Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines
por: Cao, Yunlong, et al.
Publicado: (2021)

Assessment of BIV1-CovIran inactivated vaccine–elicited neutralizing antibody against the emerging SARS-CoV-2 variants of concern
por: Salehi, Mohammadreza, et al.
Publicado: (2022)

A nasal omicron vaccine booster elicits potent neutralizing antibody response against emerging SARS-CoV-2 variants
por: Lam, Joy-Yan, et al.
Publicado: (2022)

Inactivated poliovirus type 2 vaccine delivered to rat skin via high density microprojection array elicits potent neutralising antibody responses
por: Muller, David A., et al.
Publicado: (2016)

Omicron variants escape the persistent SARS-CoV-2-specific antibody response in 2-year COVID-19 convalescents regardless of vaccination
por: Wang, Miao, et al.
Publicado: (2022)

Non-spike and spike-specific memory T cell responses after the third dose of inactivated COVID-19 vaccine
por: Huang, Ruoqiong, et al.
Publicado: (2023)

A third dose of inactivated SARS-CoV-2 vaccine induces robust antibody responses in people with inadequate response to two-dose vaccination
por: Zhou, Taicheng, et al.
Publicado: (2022)

Omicron variants breakthrough infection elicited higher specific memory immunity than third dose booster in healthy vaccinees
por: Yu, Pei, et al.
Publicado: (2023)

Intensified antibody response elicited by boost suggests immune memory in individuals administered two doses of SARS-CoV-2 inactivated vaccine
por: Liao, Yun, et al.
Publicado: (2021)

Intratumoral expression of interleukin 23 variants using oncolytic vaccinia virus elicit potent antitumor effects on multiple tumor models via tumor microenvironment modulation
por: Chen, Lingjuan, et al.
Publicado: (2021)

Potent and broad neutralization of HIV-1 by a llama antibody elicited by immunization
por: McCoy, Laura E., et al.
Publicado: (2012)

Delta breakthrough infections elicit potent, broad and durable neutralizing antibody responses
por: Walls, Alexandra C., et al.
Publicado: (2021)

Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2
por: Walls, Alexandra C., et al.
Publicado: (2020)

Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2
por: Walls, Alexandra C., et al.
Publicado: (2020)

SARS-CoV-2 breakthrough infections elicit potent, broad, and durable neutralizing antibody responses
por: Walls, Alexandra C., et al.
Publicado: (2022)

Combined anti-S1 and anti-S2 antibodies from hybrid immunity elicit potent cross-variant ADCC against SARS-CoV-2
por: Grant, Michael D., et al.
Publicado: (2023)

Different antibody responses between liver and kidney transplant recipients elicited by third doses of COVID-19 mRNA vaccines
por: Lim, So Yun, et al.
Publicado: (2023)

Infection with wild-type SARS-CoV-2 elicits broadly neutralizing and protective antibodies against omicron subvariants
por: Ju, Bin, et al.
Publicado: (2023)

Infection or a third dose of mRNA vaccine elicits neutralizing antibody responses against SARS-CoV-2 in kidney transplant recipients
por: Charmetant, Xavier, et al.
Publicado: (2022)

Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2
por: Zhang, Qi, et al.
Publicado: (2021)

Potent RBD-specific neutralizing rabbit monoclonal antibodies recognize emerging SARS-CoV-2 variants elicited by DNA prime-protein boost vaccination
por: Chen, Yuxin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o2bdb2rqi1b5inm8tjlic9ij2v